All News

Last month, April, 2002, I reviewed the malpractice crisis US ob/gyns are facing. What steps can be taken to address the current situation and how do we craft a long-term strategy to create a fair and impartial method of adjudicating malpractice claims?

While colposcopy remains an essential diagnostic tool in the hands of an experienced clinician, the five technologies outlined here may eventually replace or at least supplement this important procedure.

While most ob/gyns are well-versed in the intricacies of visually interpreting FHR tracings, a growing body of evidence suggests that a software-based approach may yield more clinically useful information.

The ob/gyn's armamentarium for contraception continues to expand, with the addition of several new sustained-release devices that may increase patient satisfaction and compliance.

A rare but potentially catastrophic obstetrical complication, placenta accreta is on the increase, given the current trend toward elective repeat C/S. Three experts detail the best approach to management, which begins with antenatal ultrasound diagnosis.

Early diagnosis and treatment could drastically reduce the high medical, psychosocial, and economic costs of chlaymydial infections. So why are screening rates so low--especially in disproportionately affected younger women--and what can we do about it?

Coding and reimbursement for Medicare well-woman screening exams is one of the biggest challenges in ob/gyn coding. You must know whether a patient meets Medicare's criteria for "high risk" or "low risk." This risk factor determines the frequency with which Medicare pays for well-woman care.